Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Loading Events

« All Events

Advanced Therapies Integrates North 2025

April 30

Advanced Therapies Integrates North 2025 brings together industry leaders to unlock the full potential of Advanced Therapies and Medicinal Products (ATMPs). The event spotlights key innovations in cell and gene therapies, regenerative medicine, tissue therapies, and other complex therapeutics, while also addressing critical industry challenges, including regulatory hurdles and commercial barriers to large-scale adoption.

By engaging a diverse network—spanning innovators, regulators, supply chain experts, technology providers, academics, industry bodies, and government-backed initiatives—Advanced Therapies Integrates aspires to be the UK’s leading platform for turning breakthrough research and disruptive technologies into real-world healthcare solutions that enhance patient outcomes and transform healthcare systems.

Go to Top